Brain abnormalities in Parkinson's patients develop before symptoms occur

January 20, 2010

Scientists who have identified brain networks damaged in Parkinson's disease have new evidence that these systems become abnormal a few years before symptoms appear. And what's more, parts of the network appear to respond in a last ditch attempt to rescue the brain.

"We were surprised," said Chris Tang, MD, PhD, a Parkinson's investigator at The Feinstein Institute for Medical Research in Manhasset, NY, and an author of the study, published this month in the Journal of Neuroscience. The Feinstein scientists have been following people with for decades. They have had a unique opportunity to take snapshots of the brain over the course of four years in 15 patients and an equal number of normal volunteers. The group initially identified two discrete abnormal networks, one that was involved in mediating the motor of Parkinson's disease, and the other that regulates the that develops in many patients with this illness.

Symptoms of Parkinson's disease initially occur on one side of the body, which provided scientists with a unique opportunity to study the brain scans at multiple times and compare the symptoms to changes in the brain networks over time. The idea for the latest study was to watch the activity of the network on the side of the brain that controls the side of the body that's free of symptoms. As the disease progresses, both sides of the body ultimately become involved.

The motor network that governed the side of the body with initial symptoms was the first to become abnormal. Scientists under the direction of David Eidelberg, MD, head of the Feinstein's Center for Neurosciences, found that the motor network on the other side of the brain was also abnormal, even though symptoms appeared only two years later. The brain network that governs cognition began showing abnormalities after two more years had passed, which was four years after their diagnosis. The average age of the patients in the study is 58 and no one has yet to develop cognition problems.

The brain scans measure glucose and dopamine, the chemical that is depleted during the disease process. By using these scans to understand what the is doing before symptoms emerge, investigators are characterizing new therapeutic targets to slow or actually prevent the onset of clinical disability in Parkinson's disease and related neurological illnesses.

Related Stories

Recommended for you

Placebo sweet spot for pain relief found in brain

October 27, 2016

Scientists have identified for the first time the region in the brain responsible for the "placebo effect" in pain relief, when a fake treatment actually results in substantial reduction of pain, according to new research ...

Team announces mapping of the mouse cortex in 3-D

October 27, 2016

The Allen Institute for Brain Science has completed the three-dimensional mapping of the mouse cortex as part of the Allen Mouse Common Coordinate Framework (CCF): a standardized spatial coordinate system for comparing many ...

Neuro chip records brain cell activity

October 26, 2016

Brain functions are controlled by millions of brain cells. However, in order to understand how the brain controls functions, such as simple reflexes or learning and memory, we must be able to record the activity of large ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.